Search Results

Filter
  • 1-10 of  17,157 results for ""Cobicistat""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Real World Data of Viral Suppression With Darunavir/Cobicistat and Dolutegravir/Rilpivirine Among Treatment-Experienced Patients Living With Multidrug-Resistant HIV.

  • Authors : Samuel PS; Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY, USA.; Department of Pharmacy, Staten Island University Hospital, Staten Island, NY, USA.

Subjects: Pyridones*/Pyridones*/Pyridones*/administration & dosage ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/administration & dosage

  • Source: Journal of pharmacy practice [J Pharm Pract] 2024 Dec; Vol. 37 (6), pp. 1400-1404. Date of Electronic Publication: 2024 Apr 29.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interaction of CYP3A4 with the inhibitor cobicistat: Structural and mechanistic insights and comparison with ritonavir.

  • Authors : Sevrioukova IF; Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, 92697-3900, USA. Electronic address: .

Subjects: Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/chemistry ; Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/Cytochrome P-450 CYP3A*/metabolism ; Ritonavir*/Ritonavir*/Ritonavir*/chemistry

  • Source: Archives of biochemistry and biophysics [Arch Biochem Biophys] 2024 Aug; Vol. 758, pp. 110071. Date of Electronic Publication: 2024 Jun 22.Publisher: Elsevier Country of Publication: United States NLM ID: 0372430 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

UPLC-PDA Approach for Simultaneous Quantification of Elvitegravir, Tenofovir, Emtricitabine and Cobicistat in Tablets: An MS-ESI Study for Degradation Products.

  • Authors : Nimmagadda RL; Department of Pharmaceutical Analysis, GITAM School of Pharmacy, GITAM (Deemed to be University), Gandhi nagar, Rushikonda, Visakhapatnam, Andhra Pradesh 530045, India.; Gummadi S

Subjects: Tablets* ; Cobicistat*/Cobicistat*/Cobicistat*/analysis ; Tenofovir*/Tenofovir*/Tenofovir*/analysis

  • Source: Journal of chromatographic science [J Chromatogr Sci] 2024 Oct 01; Vol. 62 (8), pp. 719-731.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0173225 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study.

  • Authors : Vos CF; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.; Hemminga WL

Subjects: Ketamine*/Ketamine*/Ketamine*/administration & dosage ; Ketamine*/Ketamine*/Ketamine*/pharmacokinetics ; Biological Availability*

  • Source: Pharmacotherapy [Pharmacotherapy] 2024 Jun; Vol. 44 (6), pp. 480-484. Date of Electronic Publication: 2024 May 31.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania: A Case Report.

Subjects: Dexamethasone*/Dexamethasone*/Dexamethasone*/administration & dosage ; Dexamethasone*/Dexamethasone*/Dexamethasone*/adverse effects ; Mania*/Mania*/Mania*/chemically induced

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 May-Jun 01; Vol. 44 (3), pp. 330-331. Date of Electronic Publication: 2024 Apr 06.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen.

  • Authors : Mata-Marín JA; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.; Juárez-Contreras CA

Subjects: Darunavir*/Darunavir*/Darunavir*/adverse effects ; Darunavir*/Darunavir*/Darunavir*/therapeutic use ; Darunavir*/Darunavir*/Darunavir*/administration & dosage

  • Source: Viruses [Viruses] 2024 Jul 05; Vol. 16 (7). Date of Electronic Publication: 2024 Jul 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".

  • Authors : Panza F; Department of Medical Biotechnologies, University of Siena, Siena, Italy.; Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; HIV-1*/HIV-1*/HIV-1*/drug effects

  • Source: The new microbiologica [New Microbiol] 2024 May; Vol. 47 (1), pp. 116-122.Publisher: Edizioni Internazionali srl Country of Publication: Italy NLM ID: 9516291 Publication Model: Print Cited Medium: Print ISSN: 1121-7138

Record details

×
Academic Journal

Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure.

  • Authors : Alberton F; Infectious Diseases Unit, Vita Salute San Raffaele University, Milan, Italy.; Galli L

Subjects: HIV Protease Inhibitors*/HIV Protease Inhibitors*/HIV Protease Inhibitors*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Darunavir*

  • Source: Drug design, development and therapy [Drug Des Devel Ther] 2024 Apr 10; Vol. 18, pp. 1153-1163. Date of Electronic Publication: 2024 Apr 10 (Print Publication: 2024).Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interactions of cobicistat and ritonavir in patients with HIV and its clinical consequences.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy; Cobicistat/Cobicistat/Cobicistat/*pharmacology ; Ritonavir/Ritonavir/Ritonavir/*pharmacology

  • Source: Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2020 May; Vol. 38 (5), pp. 212-218. Date of Electronic Publication: 2019 NovPublisher: Elsevier España Country of Publication: Spain NLM ID: 101777541 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  17,157 results for ""Cobicistat""